1,5-Anhydro-3- O-benzyl-2,6-dideoxy-4- O-(3,4-di- O-benzyl-2,6-dideoxy-β- d- arabino-hexopyranosyl)- d- arabino-hex-1-enitol ( 17), which corresponds to the BC fragment of various orthosomycins, was prepared from phenyl 2,3-di- O-benzyl-6-deoxy-4- O-(3,4-di- O-benzyl-2,6-dideoxy-β- d- arabino-hexopyranosyl)-1-thio-β- d-glucopyranoside ( 16) by reductive lithiation. The synthesis of 16 involved a stereoselective coupling of phenyl 2,3-di- O-benzyl-6-deoxy-1-thio-β- d-glucopyranoside ( 9) and 1,2-di- O-acetyl-3,4-di- O-benzyl-6-deoxy-β- d-glucopyranose ( 14) followed by deoxygenation at C-2′. Glycosylation of methyl 2- O-benzyl-6-deoxy-4- O-methyl-β- d-galactopyranoside ( 25) with 3,4,6-tri- O-acetyl-2-deoxy-2-phthalimido-β- d-glucopyranosyl trichloroacetimidate, followed by deamination at C-2′, led stereospecifically to methyl 2- O-benzyl-6-deoxy-4- O-methyl-3- O-(3,4,6-tri- O-acetyl-2-deoxy-β- d- arabino-hexopyranosyl)-β- d-galactopyranoside ( 26). The 2-deoxy unit of 26 was then modified by consecutive axial introduction of a C-Me group at position 3′, protection of HO-3′, and deoxygenation at C-6′, in order to obtain methyl 3- O-(3- O-benzoyl-2,6-dideoxy-3- C-methyl-β- d- arabino-hexopyranosyl)-2- O-benzyl-6-deoxy-4- O-methyl-β- d- galactopyranoside ( 39), which corresponds to the DE fragment of orthosomycins. A glycosyloxyselenation-oxidation-elimination sequence was performed on 39 and either 1,5-anhydro-3,4-di- O-benzyl-2,6-dideoxy- d- arabino-hex-1-enitol ( 40) or 1,5-anhydro-3- O-benzyl-2,6-dideoxy-4- O-(3,4-di- O-benzyl-2,6-dideoxy-β- d- arabino-hexopyranosyl)- d- arabino- hex-1-enitol ( 17) to give the CDE tri- and BCDE tetrasaccharide fragments, respectively. Each fragment contained the spiro-ortholactone junction with an ( R) configuration at the anomeric carbon atom of the C-unit.
Read full abstract